Lantern Pharma Market Sentiment

Market sentiment signals for Lantern Pharma (LTRN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 3.3% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

2 analysts

Options Flow (P/C)

—

Avg Consensus PT

$25

+3662.2%

Highest Price Target

$25

+3662.2%

Lake Street

Lowest Price Target

$25

+3662.2%

Lake Street

Short Interest

3.3%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Apr 2, 2025	Lake Street	Chad Messer—	+3662.2%	$25	Initiate	Buy
Apr 25, 2024	HC Wainwright & Co.	Emily Bodnar—	—	—	Maintained	Neutral

Insider & Market Activity News

Stocks That Hit 52-Week Lows On Monday

On Monday, 369 companies set new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 386 stocks made new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Thursday

During the session on Thursday, 461 stocks hit new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Friday

Friday's session saw 169 companies set new 52-week lows.

Benzinga Insights

Lantern Pharma 10% Owner Trades $1.54M In Company Stock

Aaron G.L. Fletcher, 10% Owner at Lantern Pharma (NASDAQ:LTRN), reported a large insider sell on November 9, according to a new SEC filing.

Benzinga Insights

Lantern Pharma 10% Owner Trades Company's Stock

Leslie W. Kreis, 10% Owner at Lantern Pharma (NASDAQ:LTRN), reported a large insider sell on November 9, according to a new SEC filing.

Benzinga Insights

Lantern Pharma Inc

ニュース

パートナーシップ

ベンジンガ・グローバル